Research Articles
The Broken Filter: Unraveling the Neurobiology of Schizophrenia
Explore the neurobiological basis of schizophrenia, from genetic factors to brain structure changes, and discover the latest research breakthroughs in understanding this complex disorder.
The Trojan Horse from Within: How a Natural Estrogen Metabolite Fights Uterine Cancer
Discover how 2-Methoxyestradiol, a natural estrogen metabolite, inhibits endometrial carcinoma cells through multiple mechanisms including cell cycle arrest and apoptosis.
A Double Whammy for Prostate Cancer: Unleashing the Immune System with a One-Two Punch
Discover how combining Ibrutinib with PD-1 checkpoint blockade creates a powerful immunotherapy approach for metastatic prostate cancer.
The Cancer-Fighting Trojan Horse: How a Graphene "Sponge" Outsmarts Drug-Resistant Tumors
Discover how a revolutionary graphene-based nanocarrier loaded with mitoxantrone is overcoming drug resistance in cancer treatment through targeted delivery.
Illuminating the Invisible: A Brighter Glow for Cellular Spycraft
Discover the breakthrough BRET-reporter technology using a yellow mutant of Renilla muelleri luciferase that revolutionizes cellular imaging with superior brightness and efficiency.
Nature's Hidden Sniper: Can a Garden Root Revolutionize Cancer Treatment?
Exploring how Raddeanin A from Anemone raddeana fights cancer through cytotoxicity, apoptosis induction, and pharmacokinetics.
The Citrus Shield: How a Natural Compound in Grapefruit Fights Brain Damage After a Stroke
Explore how naringin, a natural compound in grapefruit, protects against cerebral infarction through molecular mechanisms and potential therapeutic applications.
RalBP1: The Achilles' Heel of Ovarian Cancer?
Exploring RalBP1 as a potential therapeutic target for overcoming chemotherapy resistance in ovarian cancer
Unmasking the Double Agent: How a Common Protein Helps Leukemia Hide from Our Immune System
Discover how MUC1-C protein helps Acute Myeloid Leukemia evade immune detection by regulating PD-L1 expression through miRNA manipulation.
The Double-Agent Drug: How a Molecule from Nature Tames Transplant Rejection
Discover how FTY720, a molecular double agent derived from nature, induces lymphocyte apoptosis to prevent organ transplant rejection in rat liver allografts.